Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bimal V Patel

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The American Journal of Managed Care|June 4, 2013
Effects of coverage gap reform on adherence to diabetes medicationsFeng Zeng, Bimal V Patel, Louis Brunetti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 2, 2006
Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular riskPatrick Thiebaud, Bimal V Patel, Michael B Nichol
Health Economics|June 23, 2007
The demand for statin: the effect of copay on utilization and compliancePatrick Thiebaud, Bimal V Patel, Michael B Nichol
The American Journal of Managed Care|June 25, 2005
The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapyPatrick W Sullivan, Kavita V Nair, Bimal V Patel
Journal of Managed Care & Specialty Pharmacy|October 30, 2014
Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?Sara C Erickson, R Scott Leslie, Bimal V Patel
The American Journal of Managed Care|February 26, 2011
Part D coverage gap and adherence to diabetes medicationsQian Gu, Feng Zeng, Bimal V Patel, et al.
Clinical Therapeutics|May 1, 2012
Failure to intensify hypertension therapy after rejected aliskiren claimsFeng Zeng, Jinhee Park, Craig A Plauschinat, et al.
Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measuresR Scott Leslie, Breanne Tirado, Bimal V Patel, et al.
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Benefit restrictions and gout treatmentSharon M Wang, Gustavus A Aranda, Sara Gao, et al.
The American Journal of Managed Care|November 5, 2005
The effect of switching on compliance and persistence: the case of statin treatmentPatrick Thiebaud, Bimal V Patel, Michael B Nichol, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The American Journal of Managed Care|June 4, 2013
Effects of coverage gap reform on adherence to diabetes medicationsFeng Zeng, Bimal V Patel, Louis Brunetti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 2, 2006
Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular riskPatrick Thiebaud, Bimal V Patel, Michael B Nichol
Health Economics|June 23, 2007
The demand for statin: the effect of copay on utilization and compliancePatrick Thiebaud, Bimal V Patel, Michael B Nichol
The American Journal of Managed Care|June 25, 2005
The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapyPatrick W Sullivan, Kavita V Nair, Bimal V Patel
Journal of Managed Care & Specialty Pharmacy|October 30, 2014
Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?Sara C Erickson, R Scott Leslie, Bimal V Patel
The American Journal of Managed Care|February 26, 2011
Part D coverage gap and adherence to diabetes medicationsQian Gu, Feng Zeng, Bimal V Patel, et al.
Clinical Therapeutics|May 1, 2012
Failure to intensify hypertension therapy after rejected aliskiren claimsFeng Zeng, Jinhee Park, Craig A Plauschinat, et al.
Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measuresR Scott Leslie, Breanne Tirado, Bimal V Patel, et al.
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Benefit restrictions and gout treatmentSharon M Wang, Gustavus A Aranda, Sara Gao, et al.
The American Journal of Managed Care|November 5, 2005
The effect of switching on compliance and persistence: the case of statin treatmentPatrick Thiebaud, Bimal V Patel, Michael B Nichol, et al.
Pageof 3